The Cooper Companies, Inc. (COO)

NASDAQ: COO · USD

$59.4

-0.52 (-0.9%)· Recorded snapshot

영어 원본으로 대체KO

번역하는 동안 영어 원본을 표시 중

이 리포트는 아직 번역되지 않았습니다. 번역 대기열이 따라잡으면 몇 분 후에 새로고침하세요.

StockMarketAgent Research · Analyzed 2026-09-20

Our latest published analysis: COO rated Strong Buy

The Cooper Companies, Inc.'s published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$78.5 / share

Potential value

$92.7 / share

Upside to FV

+41.9%

from $59.4

Moat

6.5/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$10.5B
Revenue (ttm)	4.2B
Net income (ttm)	570.3M
EPS (ttm)	$2.90
Shares out	190.2M
P/E (trailing)	20.4x
P/E (forward)	11.3x
Volume	2,944,052
Beta	0.83

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.2B
Net income (ttm): 570.3M
EPS (ttm): $2.90
P/E (trailing): 20.4x
P/E (forward): 11.3x
Market cap: $10.5B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-10-31	2022-10-31	2023-10-31	2024-10-31	2025-10-31	Trend
Revenue	$2.92B	$3.31B	$3.59B	$3.90B	$4.09B	+8.8%
Gross profit	$1.96B	$2.14B	$2.36B	$2.60B	$2.68B	+8.2%
Operating income	$505.8M	$507.6M	$533.1M	$705.7M	$682.9M	+7.8%
Net income	$2.94B	$385.8M	$294.2M	$392.3M	$374.9M	-40.3%
EPS (diluted)	$14.79	$1.94	$1.48	$1.96	$1.87	-40.4%
EBITDA	$823.9M	$878.7M	$885.9M	$1.07B	$1.05B	+6.3%
R&D	$92.7M	$110.3M	$137.4M	$155.1M	$172.2M	+16.7%
SG&A	$1.21B	$1.34B	$1.50B	$1.53B	$1.63B	+7.7%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	5T	39.4x	10.8x	101.6%	+6.1%	+28.5%	매도
ABNB	Airbnb, Inc.	97.8B	37.5x	7.4x	16.8%	+24.4%	+28.5%	매도
ADBE	Adobe Inc.	97.1B	13.9x	3.7x	57.2%	+11.5%	-30.7%	적극 매수
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	매도
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	비중 축소
ALGN	Align Technology Inc.	10.9B	26.6x	2.6x	17.2%	+3.6%	+11.6%	비중 축소

Base and Bull scenarios

Base60%

Price target

$78.48

+41.9% from spot

The Base case envisions steady compounding driven by ongoing conversion to premium daily disposable contact lenses, defensive gross margins, and gradual deleveraging. Performance tracks toward Fair value of $78.48, supported by stable replacement demand across optometry networks. The thesis would be challenged if European revenue decelerates or if surgical segment margins fail to recover.

Core vision care revenue expands at a moderate pace aligned with demographic correction needs
Consolidated operating margins remain defensive within historical ranges
Surplus cash flow is directed toward continuous debt paydown

Bull20%

Price target

$92.70

+67.7% from spot

The Bull case models accelerated market share gains in specialty silicone hydrogel daily lenses across Europe and Asia, accompanied by operational integration in Cooper Surgical that lifts segment margins. This outcome delivers Potential value of $92.70 as valuation multiples expand. Slower adoption of daily modalities would disconfirm this trajectory.

Accelerated adoption of premium toric and multifocal daily disposable lenses
Operating margin expansion driven by surgical segment recovery and manufacturing efficiencies
Valuation multiple rerating toward specialized medtech peer averages

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($78.48). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	2.0%	2.5%	3.0%	3.5%	4.0%
6.7%	$96.5	$103	$111	$122	$136
7.7%	$82.6	$86.6	$91.5	$97.5	$105
8.7%	$72.7	$75.3	$78.5	$82.2	$86.7
9.7%	$65.1	$67.0	$69.2	$71.7	$74.6
10.7%	$59.2	$60.6	$62.1	$63.9	$65.9

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E11.3

P25 n/aP50 n/aP75 n/a

Trailing P/E19

P25 n/aP50 n/aP75 n/a

ROE6.8

P25 n/aP50 n/aP75 n/a

ROIC5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All COO indicators

Market & fundamental data

Available fields

281

Groups with data

Currency

USD

Showing 281 of 281 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000711404
Company name	The Cooper Companies, Inc.
Country	United States
Country code	US
CUSIP number	216648501
Earnings date	2026-12-03
Earnings time	amc
Employees	15,000
Employees change	-1,000
Employees growth	-6.25%
Enterprise value	$13.9B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-05-09
Fiscal year end	October
Founded	1980
In index	SP500
Industry	Medical Instruments & Supplies
Is primary listing	Yes
Is SPAC	No
ISIN number	US2166485019
Last 10-K release date	2025-12-05
Last earnings date	2026-09-09
Last refreshed	2026-10-28
Last stock split date	2024-02-20
Last stock split type	Forward
Market cap	$11.3B
Market cap category	Large-Cap
Next earnings date	2026-12-03
Options	Yes
Price	$59.36
Price currency	USD
Sector	Healthcare
SIC code	3851
Stock price date	2026-10-28
Symbol	COO
U.S. state	California
Website	https://www.coopercos.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	12.88x
Average P/E ratio (10Y)	42.69x
Average P/E ratio (3Y)	45.58x
Average P/E ratio (5Y)	42.39x
Earnings yield	4.89%
EV/Earnings	24.51x
EV/EBIT	25.5x
EV/EBITDA	15x
EV/FCF	20.61x
EV/Sales	3.3x
FCF / EV yield	4.85%
FCF yield	5.98%
Forward EV/Sales	3.21x
Forward P/E	13.14x
Forward P/S	2.6x
Graham number	53.50904
Graham upside	-10.19%
Industry forward P/E	22.65x
Industry P/E	75.03x
Lynch fair value	$14.52
Lynch upside	-75.62%
P/(FCF - SBC) ratio	18.65x
P/(OCF - SBC) ratio	11.77x
P/B ratio	1.37x
P/E ratio	20.44x
P/FCF ratio	16.71x
P/OCF ratio	10.96x
P/S ratio	2.67x
PEG ratio	1.93x
Price / tangible book value	3.77x
Price/EBITDA ratio	12.16x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	12.93%
EBITDA margin	22%
FCF margin	16%
Gross margin	65.93%
Operating margin	12.93%
Pretax margin	10.91%
Profit margin	13.46%
Profit per employee	$38,020
Profitable quarters	1
Profitable years	18
Revenue per employee	$282,460
ROA	2.73%
ROA (5Y)	3.46%
ROCE	5.07%
ROE	6.84%
ROE (5Y)	14.75%
ROIC	5.03%
ROIC (5Y)	4.93%
SBC / revenue	1.66%
Tax / revenue	-2.55%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	42.4%
EPS growth (Q)	357.14%
EPS growth 10Y	8.57%
EPS growth 3Y	28.16%
EPS growth 5Y	-27.67%
EPS growth quarters	1
EPS growth years	0
FCF growth	64.6%
FCF growth (Q)	65.96%
FCF growth (QoQ)	183.2%
FCF growth 3Y	45.17%
FCF growth 5Y	5.21%
Gross profit growth	3.11%
Gross profit growth (Q)	2.88%
Gross profit growth 3Y	6.47%
Gross profit growth 5Y	7.26%
Net income growth	39.85%
Net income growth (Q)	340.29%
Net income growth 3Y	27.48%
Net income growth 5Y	-27.84%
Net income growth quarters	1
Net income growth years	0
OCF growth	26.58%
OCF growth (Q)	30.72%
OCF growth (QoQ)	86.93%
OCF growth 10Y	9.4%
OCF growth 3Y	22.36%
OCF growth 5Y	5.72%
Operating income growth	-26.25%
Operating income growth (Q)	26.35%
Operating income growth 3Y	2.36%
Operating income growth 5Y	-2.11%
Revenue growth	4.73%
Revenue growth (Q)	0.56%
Revenue growth (QoQ)	-1.41%
Revenue growth 10Y	8.33%
Revenue growth 3Y	6.43%
Revenue growth 5Y	8.29%
Revenue growth quarters	23
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-355.3M
Depreciation and amortization	$384M
EBIT	$548M
EBITDA	$932M
EPS	$2.90
FCF per share	$3.57
Financing cash flow	$-641M
Free cash flow	$678M
Free cash flow minus SBC	$607.5M
Gross profit	$2.8B
Income taxes	$-107.9M
Investing cash flow	$-361.5M
Net borrowing	$66.2M
Net cash flow	$30M
Net income	$570.3M
Operating cash flow minus SBC	$962.8M
Operating income	$548M
Revenue	$4.2B
Stock-based compensation	$70.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.38
Book value per share	$43.81
Debt / EBITDA	2.83
Debt / equity	0.34
Debt / FCF	4.13
Goodwill	$3.9B
Interest coverage	6.14
Long-term assets	$10.4B
Long-term liabilities	$2.5B
Net cash (debt)	$-2.6B
Net cash / market cap	-23.36%
Net debt / EBITDA	2.84
Net debt / equity	0.32
Net debt / FCF	3.9
Piotroski F-Score	6
Property, plant and equipment	$2.1B
Shareholders' equity	$8.3B
Tangible book value	$3B
Tangible book value per share	$15.81
Total assets	$12.7B
Total cash	$154.7M
Total debt	$2.8B
Total liabilities	$4.3B
WACC	7.54%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.34
Current assets	$2.3B
Current liabilities	$1.9B
Current ratio	1.22
Inventory turnover	1.61
Net working capital	$888.3M
Quick ratio	0.51
Working capital	$414.9M
Working capital turnover	5.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.33%
Dividend growth (10Y)	0%
Dividend growth (3Y)	0%
Dividend growth (5Y)	0%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$0.01
Shareholder yield	2.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	36.26%
10Y return CAGR	3.16%
10Y total return	36.45%
150-day SMA	$65.74
15Y price change	234.32%
15Y return CAGR	8.41%
15Y total return	235.65%
1D price change	-0.87%
1M price change	7.82%
1M total return	7.82%
1W price change	1%
1W total return	1%
1Y price change	-18.04%
1Y return CAGR	-18.05%
1Y total return	-18.04%
20-day SMA	$57.56
200-day SMA	$69.12
20Y price change	312.85%
20Y return CAGR	7.41%
20Y total return	317.76%
3M price change	-15.05%
3M total return	-15.05%
3Y price change	-22.17%
3Y return CAGR	-8.01%
3Y total return	-22.17%
50-day SMA	$60.99
50-day SMA vs 200-day SMA	50under200
52-week high	$89.83
52-week high date	2025-12-05
52-week low	$51.01
52-week low date	2026-09-10
5Y price change	-42.02%
5Y return CAGR	-10.32%
5Y total return	-42%
6M price change	-7.2%
6M total return	-7.2%
All-time high	$115.90
All-time high date	2021-09-03
All-time low	$0.11
All-time low date	1993-07-20
Average true range (ATR)	$1.61
Average volume	3.2M
Beta (1Y)	-0.04
Beta (2Y)	0.56
Beta (5Y)	0.83
Change from 52-week high	-33.92%
Change from 52-week low	16.37%
Change from all-time high	-48.48%
Change from all-time low	56,497.16%
Change from open	0.85%
Day's gap	-1.7%
Dollar volume	$174.8M
High price	$60.24
Low price	$58.86
Monthly RSI	38.91
Open price	$58.86
Position in 52-week range	36.23%
Premarket change	-0.78%
Premarket close	$59.88
Premarket price	$59.41
Premarket volume	794
Previous close	$59.88
Price vs 150-day SMA	-9.17%
Price vs 20-day SMA	3.74%
Price vs 200-day SMA	-13.61%
Price vs 50-day SMA	-2.1%
Relative volume	0.92
RSI	53.9
Sharpe ratio	-0.59
Sharpe ratio (3Y)	-0.29
Sharpe ratio (5Y)	-0.34
Sortino ratio	-0.62
Sortino ratio (3Y)	-0.22
Sortino ratio (5Y)	-0.28
Volume	2.9M
Weekly RSI	42.11
YTD price change	-27.15%
YTD total return	-27.15%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	188.8M
Float percentage	99.27%
Shares change (QoQ)	-0.82%
Shares change (YoY)	-2.33%
Shares held by insiders	0.64%
Shares held by institutions	110.89%
Shares outstanding	190.2M
Short % of float	4.81%
Short % of shares	4.78%
Short ratio	1.6 days

Deeper analysis on COO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this COO report

What is the latest published COO stock rating?

The Cooper Companies, Inc. is shown with Strong Buy in the latest published report, analyzed 2026-09-20. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full COO analysis?

The full latest published report, analyzed 2026-09-20, lives at /stocks/COO/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for COO?

The latest published report analyzed 2026-09-20 gives COO a fair value of USD 78 and a potential value of USD 93. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the COO page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-09-20). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

Strong BuyCOO · Fair value $78.5+41.9%

Read full analysis →

Category	Score	Reading
Valuation	8.5
Management	6.5
Balance Sheet	6.0
Profitability	5.5
Revenue Growth	4.5
Risk Assessment	6.5
Competitive Moat	6.5
Earnings Quality	9.0
Capital Efficiency	2.5

The Cooper Companies, Inc. (COO)

Our latest published analysis: COO rated Strong Buy

Price

Financial snapshot

Fair-value bridge

Latest news · COO

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All COO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on COO

Frequently asked questions

등급 이력